Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial

ClinicalTrials.gov ID: NCT00799903

Public ClinicalTrials.gov record NCT00799903. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 2:37 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

LPL100601, A Clinical Outcomes Study of Darapladib Versus Placebo in Subjects With Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE)

Study identification

NCT ID
NCT00799903
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
GlaxoSmithKline
Industry
Enrollment
15,828 participants

Conditions and interventions

Interventions

  • Darapladib Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Sep 30, 2013
Completion
Oct 16, 2013
Last update posted
Aug 9, 2017

2008 – 2013

United States locations

U.S. sites
155
U.S. states
40
U.S. cities
135
Facility City State ZIP Site status
GSK Investigational Site Birmingham Alabama 35235
GSK Investigational Site Birmingham Alabama 35294-0007
GSK Investigational Site Huntsville Alabama 35801
GSK Investigational Site Anchorage Alaska 99508
GSK Investigational Site Little Rock Arkansas 72204
GSK Investigational Site Concord California 94520
GSK Investigational Site Lomita California 90717
GSK Investigational Site Los Angeles California 90024
GSK Investigational Site Los Angeles California 90036
GSK Investigational Site Madera California 93637
GSK Investigational Site Oakland California 94611
GSK Investigational Site Oakland California 94612
GSK Investigational Site Poway California 92064
GSK Investigational Site Sacramento California 95819
GSK Investigational Site San Diego California 92161
GSK Investigational Site San Ramon California 94582
GSK Investigational Site Santa Ana California 92705
GSK Investigational Site Spring Valley California 91978
GSK Investigational Site Thousand Oaks California 91360
GSK Investigational Site Colorado Springs Colorado 80920
GSK Investigational Site Denver Colorado 80218
GSK Investigational Site Golden Colorado 80401
GSK Investigational Site Thornton Colorado 80229
GSK Investigational Site Bridgeport Connecticut 06606
GSK Investigational Site Bridgeport Connecticut 06610
GSK Investigational Site Hartford Connecticut 06067
GSK Investigational Site Newark Delaware 19718
GSK Investigational Site Atlantis Florida 33462
GSK Investigational Site Gainesville Florida 32610
GSK Investigational Site Hollywood Florida 33023
GSK Investigational Site Jacksonville Florida 32207
GSK Investigational Site Jacksonville Florida 32216
GSK Investigational Site Jacksonville Florida 32258
GSK Investigational Site Jacksonville Beach Florida 32250
GSK Investigational Site Miami Florida 33136
GSK Investigational Site Miami Florida 33183
GSK Investigational Site Ocala Florida 34471
GSK Investigational Site Ponte Vedra Beach Florida 32081
GSK Investigational Site Conyers Georgia 30094
GSK Investigational Site Aurora Illinois 60504
GSK Investigational Site Chicago Illinois 60654
GSK Investigational Site Melrose Park Illinois 60160
GSK Investigational Site Avon Indiana 46123
GSK Investigational Site Franklin Indiana 46131
GSK Investigational Site Greenfield Indiana 46140
GSK Investigational Site Indianapolis Indiana 46256
GSK Investigational Site Indianapolis Indiana 46260
GSK Investigational Site Valparaiso Indiana 46383
GSK Investigational Site Iowa City Iowa 52242
GSK Investigational Site West Des Moines Iowa 50266
GSK Investigational Site Crestview Hills Kentucky 41017
GSK Investigational Site Louisville Kentucky 40206
GSK Investigational Site Louisville Kentucky 40213
GSK Investigational Site Lafayette Louisiana 70503
GSK Investigational Site New Iberia Louisiana 70563
GSK Investigational Site Slidell Louisiana 70458
GSK Investigational Site Auburn Maine 04210
GSK Investigational Site Bangor Maine 04401
GSK Investigational Site Scarborough Maine 04074
GSK Investigational Site Baltimore Maryland 21209
GSK Investigational Site Oxon Hill Maryland 20745
GSK Investigational Site Prince Frederick Maryland 20678
GSK Investigational Site Boston Massachusetts 02111
GSK Investigational Site Natick Massachusetts 01760
GSK Investigational Site Springfield Massachusetts 01103
GSK Investigational Site Cadillac Michigan 49601
GSK Investigational Site Detroit Michigan 48202
GSK Investigational Site Petoskey Michigan 49770
GSK Investigational Site Saint Cloud Minnesota 56303
GSK Investigational Site St Louis Missouri 63110
GSK Investigational Site Grand Island Nebraska 68803
GSK Investigational Site Las Vegas Nevada 89103
GSK Investigational Site Las Vegas Nevada 89130
GSK Investigational Site Browns Mills New Jersey 08015
GSK Investigational Site Elizabeth New Jersey 07202
GSK Investigational Site West Orange New Jersey 07052
GSK Investigational Site Albuquerque New Mexico 87102
GSK Investigational Site Buffalo New York 14215
GSK Investigational Site New York New York 10001
GSK Investigational Site New York New York 10016
GSK Investigational Site New York New York 10021
GSK Investigational Site Westfield New York 14787
GSK Investigational Site Williamsville New York 14221
GSK Investigational Site Charlotte North Carolina 28204
GSK Investigational Site Durham North Carolina 27710
GSK Investigational Site Gastonia North Carolina 28054
GSK Investigational Site Matthews North Carolina 28105
GSK Investigational Site Salisbury North Carolina 28144
GSK Investigational Site Statesville North Carolina 28677
GSK Investigational Site Wilmington North Carolina 28401
GSK Investigational Site Grand Forks North Dakota 58201
GSK Investigational Site Cincinnati Ohio 45227
GSK Investigational Site Cincinnati Ohio 45246
GSK Investigational Site Elyria Ohio 44035
GSK Investigational Site Garfield Heights Ohio 44125
GSK Investigational Site Kettering Ohio 45429
GSK Investigational Site Middleburg Heights Ohio 44130
GSK Investigational Site Sandusky Ohio 44870
GSK Investigational Site Toledo Ohio 43614
GSK Investigational Site Westlake Ohio 44145
GSK Investigational Site Oklahoma City Oklahoma 73120
GSK Investigational Site Portland Oregon 97219
GSK Investigational Site Beaver Pennsylvania 15009
GSK Investigational Site Danville Pennsylvania 17822-4201
GSK Investigational Site Doylestown Pennsylvania 18901
GSK Investigational Site Erie Pennsylvania 16502
GSK Investigational Site Jersey Shore Pennsylvania 17740
GSK Investigational Site Lewistown Pennsylvania 17044
GSK Investigational Site Philadelphia Pennsylvania 19104
GSK Investigational Site Philipsburg Pennsylvania 16866
GSK Investigational Site Pittsburgh Pennsylvania 15212
GSK Investigational Site Port Matilda Pennsylvania 16870
GSK Investigational Site Sayre Pennsylvania 18840
GSK Investigational Site Scranton Pennsylvania 18503
GSK Investigational Site Scranton Pennsylvania 18505
GSK Investigational Site Sellersville Pennsylvania 18960
GSK Investigational Site Wilkes-Barre Pennsylvania 18702
GSK Investigational Site York Pennsylvania 17403
GSK Investigational Site Providence Rhode Island 02904
GSK Investigational Site Charleston South Carolina 29401
GSK Investigational Site Charleston South Carolina 29425-6240
GSK Investigational Site Spartanburg South Carolina 29303
GSK Investigational Site Rapid City South Dakota 57701
GSK Investigational Site Sioux Falls South Dakota 57105
GSK Investigational Site Bristol Tennessee 37620
GSK Investigational Site Johnson City Tennessee 37601
GSK Investigational Site Amarillo Texas 79106
GSK Investigational Site Austin Texas 78705
GSK Investigational Site Corpus Christi Texas 78404
GSK Investigational Site Dallas Texas 75226
GSK Investigational Site Dallas Texas 75231
GSK Investigational Site Georgetown Texas 78626
GSK Investigational Site Harker Heights Texas 76548
GSK Investigational Site Houston Texas 77030
GSK Investigational Site Houston Texas 77081
GSK Investigational Site Plano Texas 75024
GSK Investigational Site San Antonio Texas 78217
GSK Investigational Site San Antonio Texas 78244
GSK Investigational Site Victoria Texas 77901
GSK Investigational Site Draper Utah 84020
GSK Investigational Site Burke Virginia 22015
GSK Investigational Site Norfolk Virginia 23502
GSK Investigational Site Richmond Virginia 23294
GSK Investigational Site Winchester Virginia 22601
GSK Investigational Site Kirkland Washington 98034
GSK Investigational Site Olympia Washington 98502
GSK Investigational Site Renton Washington 98057
GSK Investigational Site Seattle Washington 98104
GSK Investigational Site Spokane Washington 99204
GSK Investigational Site Spokane Washington 99207
GSK Investigational Site Spokane Washington 99208
GSK Investigational Site Tacoma Washington 98405
GSK Investigational Site Walla Walla Washington 99362
GSK Investigational Site Wenatchee Washington 98801
GSK Investigational Site Wausau Wisconsin 54401

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 495 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00799903, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 9, 2017 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00799903 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →